SCHEMBL16694101

SCHEMBL16694101

CC(C)c1cc(C(C)C)cc(P(C(C)(C)C)C(C)(C)C)c1

nearest known ligand 0.31

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.31
GABRB2 P47870 1/20 0.31
FABP3 P05413 1/20 0.30
FABP4 P15090 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP2D6 P10635 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29670088 0.98 GABRA1 (0.30) GABRA1GABRB2
SCHEMBL16694196 0.79 HDAC4 (0.40)
SCHEMBL29590068 0.79 HDAC4 (0.40)
SCHEMBL29670251 0.77 HDAC4 (0.39)
SCHEMBL16694097 0.76 TYR (0.38) CYP2D6
SCHEMBL29670146 0.74 TYR (0.37) CYP2D6
SCHEMBL29177231 0.73 GABRA1 (0.42) GABRA1GABRB2FABP3FABP4
SCHEMBL338867 0.72 GABRA1 (0.46) GABRA1GABRB2FABP3FABP4CYP1A2
SCHEMBL19998404 0.72 GABRA1 (0.34) GABRA1GABRB2FABP3FABP4
SCHEMBL1479773 0.70 FABP3 (0.37) GABRA1GABRB2FABP3FABP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12213376-B2 Organic photoelectric conversion material SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2025-01-28 US disclosed
US-20220310939-A1 ORGANIC PHOTOELECTRIC CONVERSION MATERIAL SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2022-09-29 US disclosed
EP-4024486-A1 ORGANIC PHOTOELECTRIC CONVERSION MATERIAL SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2022-07-06 EP disclosed
CN-110741028-B Method for producing polymer compound 住友化学株式会社 2022-05-03 CN disclosed
CN-110003271-B Process for producing aromatic compound 住友化学株式会社 2022-05-03 CN disclosed
EP-2871198-B1 METHOD FOR PRODUCING AROMATIC COMPOUND SUMITOMO CHEMICAL CO (JP) 2017-06-14 EP disclosed
US-9453103-B2 Method for producing aromatic compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-09-27 US disclosed
US-20150322199-A1 METHOD FOR PRODUCING AROMATIC COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-11-12 US disclosed
EP-2871198-A1 METHOD FOR PRODUCING AROMATIC COMPOUND Sumitomo Chemical Company Limited (JP) 2015-05-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150322199-A1 METHOD FOR PRODUCING AROMATIC COMPOUND PAH, DDC, DDT GABRA1 3212/4885GABRB2 3453/4885FABP3 4235/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.